Načítá se...
Scleroderma patients with antibodies against the large subunits of both RNA polymerases-I and -III are protected against cancer
OBJECTIVES: While compelling data suggest a cancer-induced autoimmunity model in scleroderma patients with anti-RNA polymerase III large subunit (anti-RPC155) antibodies, ~85% of these patients do not manifest cancer. We hypothesized that anti-RPC155-positive scleroderma patients without detectable...
Uloženo v:
| Vydáno v: | Arthritis Rheumatol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6717013/ https://ncbi.nlm.nih.gov/pubmed/30888702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40893 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|